TY - JOUR
T1 - ESGO–SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers
AU - Sessa, Cristiana
AU - Schneider, Dominik T.
AU - Planchamp, François
AU - Baust, Katja
AU - Braicu, Elena Ioana
AU - Concin, Nicole
AU - Godzinski, Jan
AU - McCluggage, W. Glenn
AU - Orbach, Daniel
AU - Pautier, Patricia
AU - Peccatori, Fedro A.
AU - Morice, Philippe
AU - Calaminus, Gabriele
N1 - Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/7/1
Y1 - 2020/7/1
N2 - The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma of the ovary of hypercalcaemic type. The developmental process of these guidelines is based on a systematic literature review and critical appraisal process involving an international multidisciplinary developmental group consisting of experts from relevant disciplines (paediatric oncology, paediatric surgery, medical oncology, pathology, psycho-oncology, gynaecological oncology, and reproductive endocrinology). Given the specific and often complex issues involved in treating this group of patients, fertility sparing surgery and decrease of acute and long-term toxicities from treatment were important criteria for guidelines definition. Prior to publication, the guidelines were reviewed by 54 independent international practitioners in cancer care delivery.
AB - The European Society of Gynaecological Oncology and the European Society for Paediatric Oncology jointly developed clinically relevant and evidence-based guidelines for the management of adolescents and young adults aged 15 to 25 years with non-epithelial ovarian cancers, including malignant ovarian germ cell tumours, sex cord-stromal tumours, and small cell carcinoma of the ovary of hypercalcaemic type. The developmental process of these guidelines is based on a systematic literature review and critical appraisal process involving an international multidisciplinary developmental group consisting of experts from relevant disciplines (paediatric oncology, paediatric surgery, medical oncology, pathology, psycho-oncology, gynaecological oncology, and reproductive endocrinology). Given the specific and often complex issues involved in treating this group of patients, fertility sparing surgery and decrease of acute and long-term toxicities from treatment were important criteria for guidelines definition. Prior to publication, the guidelines were reviewed by 54 independent international practitioners in cancer care delivery.
UR - http://www.scopus.com/inward/record.url?scp=85086918741&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(20)30091-7
DO - 10.1016/S1470-2045(20)30091-7
M3 - Review article
C2 - 32615119
AN - SCOPUS:85086918741
SN - 1470-2045
VL - 21
SP - e360-e368
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 7
ER -